<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04246684</url>
  </required_header>
  <id_info>
    <org_study_id>ACO/ARO/AIO-18.1</org_study_id>
    <nct_id>NCT04246684</nct_id>
  </id_info>
  <brief_title>Short-course Radiotherapy Versus Chemoradiotherapy, Followed by Consolidation Chemotherapy, and Selective Organ Preservation for MRI-defined Intermediate and High-risk Rectal Cancer Patients</brief_title>
  <official_title>Short-course Radiotherapy Versus Chemoradiotherapy, Followed by Consolidation Chemotherapy, and Selective Organ Preservation for MRI-defined Intermediate and High-risk Rectal Cancer Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Prof. Dr. med. Claus Rödel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Goethe University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The hereby proposed ACO/ARO/AIO-18.1 randomized trial aims to directly compare the newly&#xD;
      established TNT concepts applying either short-course RT according to RAPIDO, or CRT&#xD;
      according to CAO/ARO/AIO-04/-12, both followed by consolidation chemotherapy, and surgery or&#xD;
      a watch&amp;wait (W&amp;W) approach for patients with clinical complete response (cCR).&#xD;
&#xD;
      The ACO/ARO/AIO-18.1 study incorporates several novel and innovative aspects to further&#xD;
      optimize multimodal rectal cancer treatment, partly established by our preceding&#xD;
      CAO/ARO/AIO-04 and CAO/ARO/AIO-12 randomized trials: (1) patient selection is based on&#xD;
      strict, quality controlled MRI features of intermediate and high-risk characteristics (and,&#xD;
      thus, complementary to our ACO/ARO/AIO-18.2 trial in &quot;low-risk&quot; rectal cancer), (2) the CRT&#xD;
      regimens incorporates 5-FU/oxaliplatin with doses and intensities shown to be effective and&#xD;
      well-tolerated without compromising treatment compliance in CAO/ARO/AIO-04, (3) the sequence&#xD;
      of CRT, CT, and surgery/W&amp;W adopts the TNT approach as established by our CAO/ARO/AIO-12 and&#xD;
      OPRA trial, (4) surgical stratification allows for W&amp;W management for strictly selected&#xD;
      patients with clinical complete response (cCR). Thus, we hypothesize that TNT with&#xD;
      5-FU/oxaliplatin-CRT followed by consolidation chemotherapy may increase organ preservation&#xD;
      while maintaining DFS as compared to RAPIDO-like short-course RT followed by consolidation&#xD;
      chemotherapy.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 15, 2020</start_date>
  <completion_date type="Anticipated">October 14, 2028</completion_date>
  <primary_completion_date type="Anticipated">October 14, 2025</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Investigator-driven</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
    <masking_description>multicentre, open-labeled, Phase III study</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>disease-free survival (DFS)</measure>
    <time_frame>the 3 years DFS survival</time_frame>
    <description>this is defined as the time from randomisation to one of the following events: no resection of primary tumor due to progression, nonradical surgery of the primary tumor (R2 resection), locoregional recurrence after R0/1 resection of the primary tumor, nonsalvageable local regrowth in case of W&amp;W management (no salvage operation or R2 resection), metastatic disease before, at, or after surgery or W&amp;W management, second primary colorectal or other cancer, or death (all cause), whichever occurs first.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Acute and late toxicity, Incidence of Treatment-Emergent Adverse Events assessment according to NCICTCAE V.5.0</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical morbidity and complications</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of sphincter-sparing surgery</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pathological TNM-staging, Number of participants with histologically complete response</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>R0 resection rate; negative circumferential resection rate</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tumor regression grading according to Dworak</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of TME according to MERCURY</measure>
    <time_frame>3 years</time_frame>
    <description>Pathological tumor evaluations</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of W&amp;W with or without local regrowth</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cumulative incidence of local and distant recurrences</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall survival</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life arm and surgical procedures</measure>
    <time_frame>3 years</time_frame>
    <description>QLQ C30, CR29</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Translational study with FACS analyses</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>functional outcome based on Treatment, Wexner-Vaizey-Score</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">702</enrollment>
  <condition>Rectal Cancer Stage III</condition>
  <arm_group>
    <arm_group_label>Control arm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In the control arm patients receive 5x5 Gy followed by 9 cycles of consolidation chemotherapy mFOLFOX6 or alternatively 6 cycles of CAPOX, followed by re-staging at week 22-24 as established as new preferred neoadjuvant regimen by the RAPIDO trial.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Experimental arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The experimental arm starts with Fluoropyrimidin/Oxaliplatin-based CRT (1.8 Gy to 45 Gy to the primary tumor and pelvic lymph nodes; followed by sequential boost of 9 Gy to the gross tumor volume) followed by consolidation chemotherapy with 6 cycles mFOLFOX6 or alternatively 4 cycles CAPOX, followed by re-staging at week 22-24. In both arms, for patients achieving a clinical complete response (cCR), as strictly assessed by clinical investigation, endoscopy and MRI, a W&amp;W option with close follow-up is scheduled. In case of non-complete response, immediate TME surgery is performed.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oxaliplatin, 85 mg/m2</intervention_name>
    <description>85 mg/m2,2h-civ, day 22, 36, 50, 64, 78, 92, 106, 120, and 134 of therapy</description>
    <arm_group_label>Control arm</arm_group_label>
    <other_name>Control arm</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>5FU; 2400 mg/m2</intervention_name>
    <description>2400 mg/m2, 46h-civ, day 22, 36, 50, 64, 78, 92, 106, 120, 134 of therapy for Control arm</description>
    <arm_group_label>Control arm</arm_group_label>
    <other_name>5-FU, control arm</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>5FU, 250 mg/m2</intervention_name>
    <description>250 mg/m2 per day, civ, on day 1-14, day 22-35 of radiotherapy;</description>
    <arm_group_label>Experimental arm</arm_group_label>
    <other_name>Experimental arm: 5-FU</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>5FU, 2400 mg/m2</intervention_name>
    <description>2400 mg/m2,46h-civ, d64, d78, d92, d106, d120, d134 of therapy</description>
    <arm_group_label>Experimental arm</arm_group_label>
    <other_name>experimental arm</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oxaliplatin 50 mg/m2</intervention_name>
    <description>50 mg/m2, 2h-civ, d1, d8, d21, d29 of radiotherapy and</description>
    <arm_group_label>Experimental arm</arm_group_label>
    <other_name>Experimental arm</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Folinic Acid, 400 mg/m2</intervention_name>
    <description>2h-civ day 22, 36, 50, 64, 78, 92, 106, 120, and 134 of therapyfor Control arm; 400 mg/m2, 2h-civ d 64, d78, d92, d106, d120, d134 of therapy for experimental arm</description>
    <arm_group_label>Control arm</arm_group_label>
    <arm_group_label>Experimental arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Radiotherapy control, 5x5 Gy: 25 Gy</intervention_name>
    <description>Control arm: 5x5 Gy (total: 25 Gy) 5 fractions</description>
    <arm_group_label>Control arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Capecitabine, 1000 mg/m2</intervention_name>
    <description>1000 mg/m2 (twice daily) day1-14 every three weeks instead of 5FU optional</description>
    <arm_group_label>Control arm</arm_group_label>
    <arm_group_label>Experimental arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oxaliplatin 85 mg/m2</intervention_name>
    <description>85 mg/m2, 2h-civ, d64, d78, d92, d106, d120, d134 of therapy</description>
    <arm_group_label>Experimental arm</arm_group_label>
    <other_name>experimental arm</other_name>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>radiotherapy experimental, 30 x 1,8 Gy: 54 Gy</intervention_name>
    <description>30 x 1.8 Gy (total: 54 Gy), 5 fractions per week</description>
    <arm_group_label>Experimental arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Capecitabine, 825 mg/m2</intervention_name>
    <description>825 mg/m2 bid, per os, on day 1-14, 22-35 of RT instead of 5FU optional</description>
    <arm_group_label>Experimental arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oxaliplatin, 130 mg/m2</intervention_name>
    <description>day1every three weeks (optional)</description>
    <arm_group_label>Control arm</arm_group_label>
    <arm_group_label>Experimental arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  diagnosis of rectal adenocarcinoma localised 0 - 12 cm from the anocutaneous line as&#xD;
             measured by rigid rectoscopy (i.e. lower and middle third of the rectum)&#xD;
&#xD;
          -  Staging requirements: High-resolution, thin-sliced (i.e. 3mm) magnetic resonance&#xD;
             imaging (MRI) of the pelvis is the mandatory local staging procedure.&#xD;
&#xD;
          -  MRI-defined inclusion criteria: presence of at least one of the following high-risk&#xD;
             conditions:&#xD;
&#xD;
          -  any cT3 if the distal extent of the tumor is &lt; 6 cm from the anocutaneous line, or&#xD;
&#xD;
          -  cT3c/d in the middle third of the rectum (≥ 6-12 cm) with MRI evidence of extramural&#xD;
             tumor spread into the mesorectal fat of more than 5 mm (&gt;cT3b), or&#xD;
&#xD;
          -  cT3 with clear cN+ based on strict MRI-criteria&#xD;
&#xD;
          -  cT4 tumors, or&#xD;
&#xD;
          -  mrCRM+ (&lt; 1mm), or&#xD;
&#xD;
          -  Extramural venous invasion (EMVI+)&#xD;
&#xD;
          -  Trans-rectal endoscopic ultrasound (EUS) is additionally used when MRI is not&#xD;
             definitive to exclude early cT1/T2 disease in the lower third of the rectum or early&#xD;
             cT3a/b tumors in the middle third of the rectum.&#xD;
&#xD;
          -  Spiral-CT of the abdomen and chest to exclude distant metastases.&#xD;
&#xD;
          -  Aged at least 18 years. No upper age limit.&#xD;
&#xD;
          -  WHO/ECOG Performance Status 0-1&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Lower border of the tumor localised more than 12 cm from the anocutaneous line as&#xD;
             measured by rigid rectoscopy&#xD;
&#xD;
          -  Distant metastases (to be excluded by CT scan of the thorax and abdomen)&#xD;
&#xD;
          -  Prior antineoplastic therapy for rectal cancer&#xD;
&#xD;
          -  Prior radiotherapy of the pelvic region&#xD;
&#xD;
          -  Major surgery within the last 4 weeks prior to inclusion&#xD;
&#xD;
          -  Subject pregnant or breast feeding, or planning to become pregnant within 6 months&#xD;
             after the end of treatment.&#xD;
&#xD;
          -  Subject (male or female) is not willing to use highly effective methods of&#xD;
             Contraception during treatment and for 6 months after the end of treatment.&#xD;
&#xD;
          -  On-treatment participation in a clinical study in the period 30 days prior to&#xD;
             inclusion&#xD;
&#xD;
          -  Previous or current drug abuse&#xD;
&#xD;
          -  Other concomitant antineoplastic therapy&#xD;
&#xD;
          -  Serious concurrent diseases, including neurologic or psychiatric disorders (incl.&#xD;
             dementia and uncontrolled seizures), active, uncontrolled infections, active,&#xD;
             disseminated coagulation disorder&#xD;
&#xD;
          -  Clinically significant cardiovascular disease in (incl. myocardial infarction,&#xD;
             unstable angina, symptomatic congestive heart failure, serious uncontrolled cardiac&#xD;
             arrhythmia) &lt; 6 months before enrolment&#xD;
&#xD;
          -  Prior or concurrent malignancy &lt; 3 years prior to enrolment in study (Exception:&#xD;
             non-melanoma Skin cancer or cervical carcinoma FIGO stage 0-1), if the patient is&#xD;
             continuously disease-free&#xD;
&#xD;
          -  Known allergic reactions on study medication&#xD;
&#xD;
          -  Known dihydropyrimidine dehydrogenase deficiency&#xD;
&#xD;
          -  Psychological, familial, sociological or geographical condition potentially hampering&#xD;
             compliance with the study protocol and follow-up schedule (these conditions should be&#xD;
             discussed with the patient before registration in the trial).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Male and female patients with histologically confirmed diagnosis of rectal adenocarcinoma localised 0 - 12 cm from the anocutaneous line as measured by rigid rectoscopy</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Claus Roedel, Prof. Dr.</last_name>
    <phone>0049-69-6301</phone>
    <phone_ext>5130</phone_ext>
    <email>claus.roedel@kgu.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Emmanouil Fokas, Prof. Dr.</last_name>
    <phone>0049-69-6301</phone>
    <phone_ext>5130</phone_ext>
    <email>emmanouil.fokas@kgu.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Clincal Center Esslingen</name>
      <address>
        <city>Esslingen</city>
        <state>Baden-Wuerttemberg</state>
        <zip>73730</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ludger Staib, Prof. Dr.</last_name>
      <phone>0711-3103-82600</phone>
      <email>l.staib@klinikum-esslingen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Clinic Freiburg</name>
      <address>
        <city>Freiburg</city>
        <state>Baden-Wuerttemberg</state>
        <zip>79106</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Simon Kirste, Dr. med.</last_name>
      <phone>0761-270-94610</phone>
      <email>simon.kirste@uniklinik-freiburg.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Clinic Mannheim</name>
      <address>
        <city>Mannheim</city>
        <state>Baden-Wuerttemberg</state>
        <zip>68167</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ralf-Dieter Hofheinz, Prof.Dr.med.</last_name>
      <phone>0621-383 28 55</phone>
      <email>ralf.hofheinz@umm.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinic Ostlab, Staufenclinic Schwaeb.Gmuend, Mutlangen</name>
      <address>
        <city>Mutlangen</city>
        <state>Baden-Wuerttemberg</state>
        <zip>73557</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Holger Herbart, Prof.Dr.</last_name>
      <email>holger.hebart@kliniken-ostlab.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pi.Tri-Studien GmbH, Offenburg</name>
      <address>
        <city>Offenburg</city>
        <state>Baden-Wuerttemberg</state>
        <zip>77654</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Henning Pelz, Dr.</last_name>
      <email>h.pelz@onkologie-offenburg.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medius Clincal Center Ostfildern-Ruit</name>
      <address>
        <city>Ostfildern</city>
        <state>Baden-Wuerttemberg</state>
        <zip>73760</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthias Geiger, Dr. med.</last_name>
      <phone>0711-4488-11660</phone>
      <email>m.geiger@medius.kliniken.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinic Stuttgart</name>
      <address>
        <city>Stuttgart</city>
        <state>Baden-Wuerttemberg</state>
        <zip>70174</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc Münter, Prof.Dr.</last_name>
      <email>m.muenter@klinikum-stuttgart.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Clinic for Radioncology Tübingen</name>
      <address>
        <city>Tübingen</city>
        <state>Baden-Wuerttemberg</state>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cihan Gani, Dr. med.</last_name>
      <phone>07071-2968338</phone>
      <email>cihan.gani@med.uni-tuebingen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Clinic Ulm</name>
      <address>
        <city>Ulm</city>
        <state>Baden-Wuerttemberg</state>
        <zip>89081</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Thomas Wiegel, Prof.Dr.</last_name>
      <email>Thomas.wiegel@uniklinik-ulm.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clincal Center &quot;St. Marien&quot; Amberg</name>
      <address>
        <city>Amberg</city>
        <state>Bavaria</state>
        <zip>92224</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ludwig Fischer von Weikersthal, Dr. med.</last_name>
      <phone>9621-38-1637</phone>
      <email>Weikersthal.ludwig@klinikum-amberg.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinic Bayreuth GmbH</name>
      <address>
        <city>Bayreuth</city>
        <state>Bavaria</state>
        <zip>95445</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Winfried Melzner, Dr.med.</last_name>
      <email>winfrid.melzner@klinikum-bayreuth.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinical Center Coburg</name>
      <address>
        <city>Coburg</city>
        <state>Bavaria</state>
        <zip>96450</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gerhard Grabenbauer, Prof. Dr.</last_name>
      <phone>09561-249125</phone>
      <email>gg@diestrahlentherapeuten.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Clinic Erlangen</name>
      <address>
        <city>Erlangen</city>
        <state>Bavaria</state>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rainer Fietkau, Prof. Dr.</last_name>
      <phone>09131-85-33405</phone>
      <email>rainer.fietkau@uk-erlangen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikverbund Allgäu</name>
      <address>
        <city>Kempten</city>
        <state>Bavaria</state>
        <zip>87439</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Langer, Prof.Dr.med.</last_name>
      <email>christian.langer@klinikum-kempten.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Technical University Clinic Munich</name>
      <address>
        <city>München</city>
        <state>Bavaria</state>
        <zip>81675</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephanie E. Combs, Prof.Dr.med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Technical University Munich</name>
      <address>
        <city>München</city>
        <state>Bavaria</state>
        <zip>81675</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefanie Combs, Prof. Dr. med.</last_name>
      <phone>089-4140-4501</phone>
      <email>stefanie.combs@tum.de</email>
    </contact>
    <contact_backup>
      <last_name>Hendrik Dapper, Dr. med.</last_name>
      <phone>089-4140-5681</phone>
      <email>hendrik.dapper@mri.de</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Clincal Center &quot;Bogenhausen&quot; Munich</name>
      <address>
        <city>München</city>
        <state>Bavaria</state>
        <zip>81925</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Fuchs, Dr. med.</last_name>
      <phone>089-9270-2462</phone>
      <email>Martin.fuchs@muenchen-klinik.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital &quot;Barmherzige Brüder&quot; Regensburg</name>
      <address>
        <city>Regensburg</city>
        <state>Bavaria</state>
        <zip>93046</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anke Schlenska-Lange, Dr. med.</last_name>
      <phone>0941-369-2151</phone>
      <email>anke.schlenska-lange@barmherzige-regensburg.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Clinic Regensburg</name>
      <address>
        <city>Regensburg</city>
        <state>Bavaria</state>
        <zip>93053</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Felix Steger, Dr. med.</last_name>
      <phone>0941-944-7610</phone>
      <email>felix.steger@ukr.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinic Nordoberpfalz AG, Clinic Weiden</name>
      <address>
        <city>Weiden</city>
        <state>Bavaria</state>
        <zip>92637</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Frank Kullmann, Prof.Dr.med.</last_name>
      <email>frank.kullmann@kliniken-nordoberpfalz.ag</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Clinic Würzburg</name>
      <address>
        <city>Würzburg</city>
        <state>Bavaria</state>
        <zip>97080</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bülent Polat, PD Dr. med.</last_name>
      <phone>0931-201-28918</phone>
      <email>polat_b@klinik.uni-wuerzburg.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clincal Center Helios Bad Saarrow</name>
      <address>
        <city>Bad Saarow</city>
        <state>Brandenburg</state>
        <zip>15526</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel Pink, PD Dr. med.</last_name>
      <phone>033631-73527</phone>
      <email>daniel.pink@helios-gesundheit.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clincal Center Darmstadt</name>
      <address>
        <city>Darmstadt</city>
        <state>Hessen</state>
        <zip>64283</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Weiß, Prof.Dr.med.</last_name>
      <phone>06151-1076851</phone>
      <email>christan.weiss@mail.klinikum-darmstadt.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinic North West gGmbH Frankfurt</name>
      <address>
        <city>Frankfurt am Main</city>
        <state>Hessen</state>
        <zip>60488</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Thorsten Götze, PD Dr.med.</last_name>
      <email>goetze.thorsten@khnw.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinic Fulda</name>
      <address>
        <city>Fulda</city>
        <state>Hessen</state>
        <zip>36043</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Katrin Schulze, Dr.</last_name>
      <email>Ksculze.RAZ@klinikum-fulda.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>DRK Clincal Centers North Hessen Kassel</name>
      <address>
        <city>Kassel</city>
        <state>Hessen</state>
        <zip>34121</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mathias Kleiß, Dr. med.</last_name>
      <phone>0561-3086-74100</phone>
      <email>kleiss@drk-nh.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Clinic Marburg</name>
      <address>
        <city>Marburg</city>
        <state>Hessen</state>
        <zip>35043</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rita Engenhart-Cabillic, Prof.Dr.med.</last_name>
      <phone>06421-5866-434</phone>
      <email>Rita.Engenhart-Cabillic@uk-gm.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sana Clinical Center Offenbach</name>
      <address>
        <city>Offenbach</city>
        <state>Hessen</state>
        <zip>63069</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silla Hey-Koch, Dr. med.</last_name>
      <phone>069-8405-7491</phone>
      <email>silla.hey-koch@sana.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Lahn-Dill Clinics Wetzlar</name>
      <address>
        <city>Wetzlar</city>
        <state>Hessen</state>
        <zip>35578</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wolfram Wannack</last_name>
      <phone>06441-7922380</phone>
      <email>wolfram.wannack@lahn-dill-kliniken.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>MVZ Oncological Cooperation Harz</name>
      <address>
        <city>Goslar</city>
        <state>Lower Saxony</state>
        <zip>38642</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mark-Oliver Zahn, Dr.med.</last_name>
      <email>m-o.zahn@onkologie-goslar.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Clinic Göttingen</name>
      <address>
        <city>Göttingen</city>
        <state>Lower Saxony</state>
        <zip>37075</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lena-Christin Conradi, Dr. Dr. med.</last_name>
      <phone>0551-39-8323</phone>
      <email>lena.conradi@med.uni-goettingen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hematological-Oncological Practice Dr. Oleg Rubanov, Hameln</name>
      <address>
        <city>Hameln</city>
        <state>Lower Saxony</state>
        <zip>31785</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Oleg Rubanov, Dr.med.</last_name>
      <email>rubanov@onkologie-rubanov.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical Project Hannover</name>
      <address>
        <city>Hannover</city>
        <state>Lower Saxony</state>
        <zip>30171</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Koenigsmann, Prof.Dr.med.</last_name>
      <phone>0511-89979680</phone>
      <email>koenigsmann@onkologie-hannover.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>&quot;St. Bernward&quot; Clincal Center Hildesheim</name>
      <address>
        <city>Hildesheim</city>
        <state>Lower Saxony</state>
        <zip>31134</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ulrich Kaiser, Prof.Dr.med.</last_name>
      <phone>05121-901274</phone>
      <email>prof.dr.u.kaiser@bernward-khs.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oncology in Medicinum Hildesheim</name>
      <address>
        <city>Hildesheim</city>
        <state>Lower Saxony</state>
        <zip>31135</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Werner Freier, Dr. med.</last_name>
      <phone>051-2191-291421</phone>
      <email>Study-nurse@onkologie-hildesheim.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oncology UnterEms, Leer</name>
      <address>
        <city>Leer</city>
        <state>Lower Saxony</state>
        <zip>26789</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lothar Müller, Dr.</last_name>
      <email>Lothar.mueller@onkologie-ue.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pius Hospital, Oldenburg</name>
      <address>
        <city>Oldenburg</city>
        <state>Lower Saxony</state>
        <zip>25121</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frank Griesinger, Prof.Dr.med.</last_name>
      <email>frank.griesinger@pius-hospital.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Clinic Oldenburg</name>
      <address>
        <city>Oldenburg</city>
        <state>Lower Saxony</state>
        <zip>26133</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claus-Henning Köhne, Prof.Dr.med.</last_name>
      <phone>0441-403-2611</phone>
      <email>onkologie@klinikum-oldenburg.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinic Wolfsburg</name>
      <address>
        <city>Wolfsburg</city>
        <state>Lower Saxony</state>
        <zip>38440</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nils Homann, Prof.Dr.</last_name>
      <email>nils.homann@klinikum.wolfsburg.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Clinic Rostock</name>
      <address>
        <city>Rostock</city>
        <state>Mecklenburg Western Pomerania</state>
        <zip>18059</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guido Hildebrandt, Prof.Dr.</last_name>
      <email>guido.hildebrandt@med.uni-rostock.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Josef Hospital of the catholic clinic Bochum</name>
      <address>
        <city>Bochum</city>
        <state>North Rhine Westphalia</state>
        <zip>44791</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Anke Reinacher-Schick, Prof.Dr.med.</last_name>
      <email>anke.reinacher@rub.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Brother clinic St. Josef, Paderborn</name>
      <address>
        <city>Paderborn</city>
        <state>North Rhine Westphalia</state>
        <zip>33098</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Tobias Gaska, Dr.med.</last_name>
      <email>t.gaska@bk-paderborn.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Evangelical Clinic Wesel</name>
      <address>
        <city>Wesel</city>
        <state>North Rhine Westphalia</state>
        <zip>46485</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Olaf Hansel, Dr.med.</last_name>
      <email>olaf.hansen@evkwesel.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Franziskus Hospital Bielefeld</name>
      <address>
        <city>Bielefeld</city>
        <state>North Rhine-Westphalia</state>
        <zip>33615</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jörg Thomas Hartmann, Prof.Dr.med.</last_name>
      <phone>0521-589-1201</phone>
      <email>joerg.Hartmann@franziskus.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Bochum</name>
      <address>
        <city>Bochum</city>
        <state>North Rhine-Westphalia</state>
        <zip>44892</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Pohl, Dr. med.</last_name>
      <phone>0234-299-80400</phone>
      <email>michael.a.pohl@web.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinic Lippe GmbH (Lemgo/Detmold)</name>
      <address>
        <city>Detmold</city>
        <state>North Rhine-Westphalia</state>
        <zip>32756</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Constantin, Dr.med.</last_name>
      <email>christian.constantin@klinikum-lippe.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Clinic Essen</name>
      <address>
        <city>Essen</city>
        <state>North Rhine-Westphalia</state>
        <zip>45122</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Gauler, Dr. med.</last_name>
      <phone>0201-723-85057</phone>
      <email>Thomas.gauler@uk-essen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinical Center &quot;Essen Mitte&quot;</name>
      <address>
        <city>Essen</city>
        <state>North Rhine-Westphalia</state>
        <zip>45136</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Müller, Dr. med.</last_name>
      <phone>020-1174-24003</phone>
      <email>ch.mueller@kem-med.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinic Maria Hilf GmbH</name>
      <address>
        <city>Mönchengladbach</city>
        <state>North Rhine-Westphalia</state>
        <zip>41063</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ullrich Graeven, Prof.Dr.med</last_name>
      <email>ullrich.graeven@mariahilf.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Vincenz Hospital Paderborn</name>
      <address>
        <city>Paderborn</city>
        <state>North Rhine-Westphalia</state>
        <zip>33098</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jobst Greeve, Prof.Dr.med.</last_name>
      <phone>05251-86-1101</phone>
      <email>j.greeve@vincenz.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Prosper Hospital Recklinghausen</name>
      <address>
        <city>Recklinghausen</city>
        <state>North Rhine-Westphalia</state>
        <zip>45659</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Höhler, Prof. Dr.</last_name>
      <phone>02361-54-2650</phone>
      <email>thomas.hoehler@prosper-hospital.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mathias-Spital, Rheine</name>
      <address>
        <city>Rheine</city>
        <state>North Rhine-Westphalia</state>
        <zip>48431</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefan Zicholl</last_name>
      <email>s.zicholl@mathias-spital.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Clinic Mainz</name>
      <address>
        <city>Mainz</city>
        <state>Rhineland-Palantine</state>
        <zip>55116</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tilman Bostel, Dr.med</last_name>
      <email>tilman.bostel@unimedizin-mainz.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinical Center &quot;Mutterhaus&quot; Trier</name>
      <address>
        <city>Trier</city>
        <state>Rhineland-Palatinate</state>
        <zip>54290</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rolf Mahlberg, Dr. med.</last_name>
      <phone>0651-9472571</phone>
      <email>mahlberg@mutterhaus.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CaritasClinic Saarbrücken</name>
      <address>
        <city>Saarbrücken</city>
        <state>Saarland</state>
        <zip>66113</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Manfred Lutz, Prof.Dr.</last_name>
      <email>m.lutz@caritasklinikum.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Clinic Magdeburg</name>
      <address>
        <city>Magdeburg</city>
        <state>Saxony-Anhalt</state>
        <zip>39120</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Thomas Brunner, Prof.Dr.</last_name>
      <email>thomas.brunner@med.ovgu.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clincal Center Chemnitz</name>
      <address>
        <city>Chemnitz</city>
        <state>Saxony</state>
        <zip>09113</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gunther Klautke, PD Dr. med.</last_name>
      <phone>0371-333-42538</phone>
      <email>g.klautke@skc.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Radiotherapy Practice Dr. A. Schreiber, Dresden</name>
      <address>
        <city>Dresden</city>
        <state>Saxony</state>
        <zip>01067</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jörg Zimmer, Dr.med.</last_name>
      <email>joerg.zimmer@klinikum-dresden.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oncology Practice Dresden</name>
      <address>
        <city>Dresden</city>
        <state>Saxony</state>
        <zip>01307</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lutz Jacobasch, Dr. med.</last_name>
      <phone>0351-4400228</phone>
      <email>jacobasch@onkologie-dresden.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Clinic Leipzig</name>
      <address>
        <city>Leipzig</city>
        <state>Saxony</state>
        <zip>04103</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Kuhnt, Prof. Dr.</last_name>
      <phone>0341-9718400</phone>
      <email>thomas.kuhnt@medizin.uni-leipzig.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinic Sankt Georg gGmbH, Leipzig</name>
      <address>
        <city>Leipzig</city>
        <state>Saxony</state>
        <zip>04129</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>André Liebmann, Dr.med.</last_name>
      <email>andre.liebmann@sanktgeorg.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Clinic Kiel</name>
      <address>
        <city>Kiel</city>
        <state>Schleswig-Holstein</state>
        <zip>24105</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Thomas Becker, Prof.Dr.</last_name>
      <email>Sekretariat.profbecker@uksh.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vivantes Clincial Center in Friedrichshain</name>
      <address>
        <city>Berlin</city>
        <zip>10249</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Andreas W. Berger, PD Dr. med.</last_name>
      <phone>030-1302-32481</phone>
      <email>Andreas.berger@vivantes.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clincal Center Helios Berlin Buch</name>
      <address>
        <city>Berlin</city>
        <zip>13125</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Reichardt, PD Dr. med.</last_name>
      <phone>030-9401-54800</phone>
      <email>peter.reichardt@helios-gesundheit.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of Radiooncology</name>
      <address>
        <city>Frankfurt</city>
        <zip>60590</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claus Roedel, Prof. Dr.</last_name>
      <phone>0049-69-6301</phone>
      <phone_ext>5130</phone_ext>
      <email>claus.roedel@kgu.de</email>
    </contact>
    <contact_backup>
      <last_name>Emmanouil Fokas, Prof. Dr. Dr.</last_name>
      <phone>0049-69-6301</phone>
      <phone_ext>5130</phone_ext>
      <email>emmanouil.fokas@kgu.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>January 23, 2020</study_first_submitted>
  <study_first_submitted_qc>January 28, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 29, 2020</study_first_posted>
  <last_update_submitted>June 15, 2021</last_update_submitted>
  <last_update_submitted_qc>June 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Goethe University</investigator_affiliation>
    <investigator_full_name>Prof. Dr. med. Claus Rödel</investigator_full_name>
    <investigator_title>Prof. Dr. med.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rectal Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Leucovorin</mesh_term>
    <mesh_term>Folic Acid</mesh_term>
    <mesh_term>Capecitabine</mesh_term>
    <mesh_term>Fluorouracil</mesh_term>
    <mesh_term>Oxaliplatin</mesh_term>
    <mesh_term>Levoleucovorin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

